ERR
HOME HELP FEEDBACK ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Correction for -M. Beeh, EUROPEAN RESPIRATORY REVIEW 16 (104) 85-87.
EUROPEAN RESPIRATORY REVIEW, 2007;16: 211. doi:10.1183/09059180.50010405
© 2007 the European Respiratory Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrow Request Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

"WHICH PATIENTS SHOULD BE TREATED WITH ANTI-IGE?". K-M. BEEH. EUR RESPIR REV 2007; 16: 104, 85–87.

Unfortunately, the dosage information in figure 1Go of the above article was presented incorrectly. The figure should have appeared as seen below.


Figure 1
View larger version (27K):
[in this window]
[in a new window]

  		FIGURE 1. Omalizumab dosing table (European Union). Ig: immunoglobulin; Q4 weeks: total dose to be administered every 4 weeks; Q2 weeks: half of total dose to be administered every 2 weeks.

 





This Article
Right arrow Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrow Request Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

HOME HELP FEEDBACK ARCHIVE SEARCH TABLE OF CONTENTS